1. Search Result

Search Result

Results for "arry-380" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-16069
    Tucatinib

    Irbinitinib; arry-380; ONT-380

    EGFR Cancer
    Tucatinib (Irbinitinib) is a potent, orally active and selective HER2 inhibitor with an IC50 of 8 nM.
  • HY-10531
    ARRY-380 (analog )

    EGFR Cancer
    ARRY-380 analog, an inhibitor of EGFR (ErbB1), is extracted from patent WO2015153959A2, compound 249. ARRY-380 is a potent, selective, ATP-competitive, orally active inhibitor of HER2.
  • HY-16069A
    Tucatinib hemiethanolate

    Irbinitinib hemiethanolate; arry-380 hemiethanolate; ONT-380 hemiethanolate

    EGFR Cancer
    Tucatinib (Irbinitinib) hemiethanolate is a potent, orally active and selective HER2 inhibitor with an IC50 of 8 nM.